Where we go with hepatocellular carcinoma: Past, present, and future perspectives

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 9, Issue 6, 2002, Pages 683-685

  Okuda, Kunio ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholangiocarcinoma; Hepatitis C virus; Hepatocellular carcinoma; Nonviral carcinogens

Indexed keywords

ALCOHOL; CAROTENOID; EOSIN; HEMOLYSIN; INTERFERON; IODINATED POPPYSEED OIL;

ARTIFICIAL EMBOLISM; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EARLY DIAGNOSIS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER RESECTION; LIVER SURGERY; LIVER TRANSPLANTATION; MEDICAL LITERATURE; MEDICAL RESEARCH; PRECANCER; PRIMARY PREVENTION; RADIOFREQUENCY RADIATION; REVIEW; STEM CELL TRANSPLANTATION; TREATMENT PLANNING;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS;

EID: 0036974850     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340200094     Document Type: Review

References (38)

1. Eggel H (1910) Ueber das primäre Carcinom der Leber. Beitr Pathol Anat 30:506-604
2. Yamagiwa K (1911) Zum Kenntniss des primären parenchymatosen Leberkarzinoms ("Hepatoma"). Virchows Arch Pathol Anat 203:75-131
3. Berman C (1951) Primary carcinoma of the liver. Lewis, London
4. Higginson J (1956) Primary carcinoma of the liver in Africa. Br J Cancer 10:609-622
5. Okuda K, Peters RL, Simson IW (1984) Gross anatomical features of hepatocellular carcinoma from three disparate geographic areas: proposal of new classification. Cancer 54:2165-2173
6. Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi R, Sakamoto K, Ikari T (1983) Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases of autopsies in ten years. Cancer 51:863-877
7. Szmuness W (1978) Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 24:40-69
8. Iwama S, Ohnishi K, Nakajima Y, Ohtsuki J, Khono K, Tsuchiya S, Higama Y, Nakayama T, Omata M, Okuda K (1982) A clinical study of hepatocellular carcinoma (HCC) in relation to hepatitis B seromarkers: implication of non-A, non-B hepatitis (NANB). Hepatology 2:117 (abstract)
9. Okuda K, Fujimori I, Hanai A, Urano Y (1987) Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 47:4967-4972
10. Okuda K, Nakanuma Y, Miyazaki M (2002) Cholangiocarcinoma: recent progress. J Gastroenterol Hepatol 17:1049-1055
11. Okuda K, Liver Cancer Study Group of Japan (1980) Primary liver cancer in Japan. Cancer 45:2663-2669
12. Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Ann Surg 211:277-287
13. Okuda K (1986) Early recognition of hepatocellular carcinoma. Hepatology 6:729-738
14. Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K (1986) Emergence of malignant lesions within an adenomatosus hyperplastic nodule in a cirrhotic liver: observations in five cases. Gastroenterology 91:198-208
15. Hirohashi S, Sakamoto M (1992) Hepatocellular carcinoma in the early stage. In: Tobe T, Kameda H, Okudaira M, Ohto M, Endo Y, Mito M, Okamoto E, Tanikawa K, Kojiro M (eds) Primary liver cancer in Japan. Springer, Berlin Heidelberg New York Tokyo, pp 25-30
16. Fearon ER (1995) Molecular genetics of colorectal cancer. Ann NY Acad Sci 768:101-110
17. Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, Chen DS (2001) Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 121:699-709
18. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Takashima T, Nakanuma Y, Unoura M (1991) Benign and malignant nodules in the cirrhotic livers: distinction based on blood supply. Radiology 178:493-497
19. Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Chung H, Kawasaki T, Maekawa K (2001) Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 221:721-730
20. Kudo M (1999) Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 19:297-307
21. Konno T, Maeda H, Iwai K, Tashiro S, Maki S, Morinaga T, Mochinaga M, Hiraoka T, Yokoyama I (1983) Effect of arterial administration of high-molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol 19:1053-1065
22. Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154:19-24
23. Ohto M, Ebara M, Yoshikawa M, Okuda K (1987) Radiation therapy and percutaneous ethanol injection for the treatment of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds) Neoplasms of the liver. Springer, Berlin Heidelberg New York Tokyo, pp 335-341
24. Okada S (1999) Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 19:323-344
25. Rossi S, Fornari F, Buscarrini L (1993) Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol 8:97-103
26. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, van Thiel DH, Carr B, Selby R (1991) Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214:221-224
27. Mazzaferro V, Regallia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699
28. Tanaka A, Tanaka K, Kaihara S, Ueda M, Uemoto S, Kiuchi T, Egawa H (2001) Liver transplantation for hepatocellular carcinoma. Nippon Rinsho 59 (suppl 6):705-716
29. Stange J, Hassnein TI, Meehta R, Mitzner SR, Bartlett RH (2002) The molecular adsorption recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 26:103-110
30. Patzer JF (2001) Advances in bioartificial liver assist devices. Ann NY Acad Sci 944:320-333
31. Chang M, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336:1855-1859
32. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, Kawanishi M (1993) A multivariate analysis of risk factors for hepatocellular carcinoma: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:47-53
33. Seeff LB, Hollinger B, Alter H, Wright GC, Cain CMB, Buskell ZJ, Ishak KG, Iber FL, Toro D, Samanta A, Kovatz RL, Perrillo RP, Goodman ZD, Knodell RG, Gitnick, G, Morgan TR, Schiff ER, Lasky S, Stevens C, Vlahcevic RZ, Weinshel E, Tanwandee T, Lin HJ, Barbosa L (2001) Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a national heart, lung, and blood institute collaborative study. Hepatology 33:455-463
34. Barrett S, Goh J, Ryan E, Stewart S, D'Keane CA, Crowe JC (2001) The natural course of hepatitis C virus infection after 22 years in a unique homogeneous cohort spontaneous viral clearance and chronic HCV infection. Gut 49:423-430
35. Wiese N, Berr WM, Porst LM, Oessen U for the East German Hepatitis C Study Group (2001) Low frequency of cirrhosis in a hepatitis C (genotype lb) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 32:91-96
36. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Tokosuka O, Kinoyama S, Yamada G (1999) Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhosis and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 131:174-181
37. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S (1995) Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346:1051-1055
38. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 344:1561-1567